Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging

被引:253
作者
McEwen, BS [1 ]
机构
[1] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 10期
关键词
D O I
10.1053/S0026-0495(03)00295-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individual differences in the aging process can be conceptualized as an accumulation of wear and tear of daily experiences and major life stressors that interact with the genetic constitution and predisposing early life experiences. The neuroendocrine system, autonomic nervous system, and immune system are mediators of adaptation to challenges of daily life, referred to as allostasis, meaning "maintaining stability through change." Physiological mediators such as adrenalin from the adrenal medulla, glucocorticoids from the adrenal cortex, and cytokines from cells of the immune system act upon receptors in various tissues and organs to produce effects that are adaptive in the short run but can be damaging if the mediators are not shut off when no longer needed. When release of the mediators is not efficiently terminated, their effects on target cells are prolonged, leading to other consequences that may include receptor desensitization and tissue damage. This process has been named "allostatic load," and it refers to the price the tissue or organ pays for an overactive or inefficiently managed allostatic response. Therefore, allostatic load refers to the "cost" of adaptation. This article discusses the mediators of allostasis and their contributions to allostatic load as well as their role in resilience of the aging organism to stressful experiences. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:10 / 16
页数:7
相关论文
共 64 条
[11]  
BULLOCH K, 2000, HDB PHYSL, P353
[12]   Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome [J].
Cannon, JG ;
Angel, JB ;
Abad, LW ;
Vannier, E ;
Mileno, MD ;
Fagioli, L ;
Wolff, SM ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) :253-261
[13]   Acute phase responses and cytokine secretion in chronic fatigue syndrome [J].
Cannon, JG ;
Angel, JB ;
Ball, RW ;
Abad, LW ;
Fagioli, L ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (06) :414-421
[14]   Brain-derived TNFα:: involvement in neuroplastic changes implicated in the conscious perception of persistent pain [J].
Covey, WC ;
Ignatowski, TA ;
Knight, PR ;
Spengler, RN .
BRAIN RESEARCH, 2000, 859 (01) :113-122
[15]   Stress-induced enhancement of skin immune function:: A role for γ interferon [J].
Dhabhar, FS ;
Satoskar, AR ;
Bluethmann, H ;
David, JR ;
McEwen, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2846-2851
[16]  
DOWDELL K, 2000, COPING ENV NEURAL EN, V4, P451
[17]   DHEA-S selectively impairs contextual-fear conditioning: Support for the antiglucocorticoid hypothesis [J].
Fleshner, M ;
Pugh, CR ;
Tremblay, D ;
Rudy, JW .
BEHAVIORAL NEUROSCIENCE, 1997, 111 (03) :512-517
[18]  
Formiga F, 1997, CLIN EXP RHEUMATOL, V15, P387
[19]  
Geronimus Arline T., 1992, Ethnicity and Disease, V2, P207
[20]  
Goldstein D. S., 2000, COPING ENV NEURAL EN, P21